Paper32251007
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
Williamson SR and 7 others. Am J Surg Pathol, 2020. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. Papers, record 32251007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32251007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Humans | |
| Immunohistochemistry | |
| In Situ Hybridization, Fluorescence | |
| Mutation | |
| Neoplasm Metastasis | |
| Neoplastic Syndromes, Hereditary | |
| Pathology, Clinical | |
| Pathology, Molecular | |
| Prognosis | |
| Societies, Medical | |
| Urology |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH |
Source NIH RePORTER
References226
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30987368 | Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30987368 | PubMed |
| 2 | 31371341 | PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31371341 | PubMed |
| 3 | 19390420 | Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. | Am J Surg Pathol | 2009 | https://conductscience.org/library/papers/19390420 | PubMed |
| 4 | 22892601 | Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. | Am J Surg Pathol | 2012 | https://conductscience.org/library/papers/22892601 | PubMed |
| 5 | 26848800 | Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene. | Am J Surg Pathol | 2016 | https://conductscience.org/library/papers/26848800 | PubMed |
| 6 | 27604489 | Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. | Cancer Discov | 2016 | https://conductscience.org/library/papers/27604489 | PubMed |
| 7 | 30383394 | Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas. | Arch Pathol Lab Med | 2019 | https://conductscience.org/library/papers/30383394 | PubMed |
| 8 | 21213368 | ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. | Genes Chromosomes Cancer | 2011 | https://conductscience.org/library/papers/21213368 | PubMed |
| 9 | 21267700 | Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. | Med Mol Morphol | 2010 | https://conductscience.org/library/papers/21267700 | PubMed |
| 10 | 26988177 | Clear cell renal cell tumors: Not all that is "clear" is cancer. | Urol Oncol | 2016 | https://conductscience.org/library/papers/26988177 | PubMed |
| 11 | 25438924 | Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. | Ann Diagn Pathol | 2014 | https://conductscience.org/library/papers/25438924 | PubMed |
| 12 | 29239034 | Succinate dehydrogenase (SDH)-deficient neoplasia. | Histopathology | 2018 | https://conductscience.org/library/papers/29239034 | PubMed |
| 13 | 26655904 | The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis. | Cell Rep | 2015 | https://conductscience.org/library/papers/26655904 | PubMed |
| 14 | 9140397 | Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. | Nat Genet | 1997 | https://conductscience.org/library/papers/9140397 | PubMed |
| 15 | 31135486 | Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study. | Am J Surg Pathol | 2019 | https://conductscience.org/library/papers/31135486 | PubMed |
| 16 | 31993771 | ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology. | Virchows Arch | 2020 | https://conductscience.org/library/papers/31993771 | PubMed |
| 17 | 19396149 | Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. | Mod Pathol | 2009 | https://conductscience.org/library/papers/19396149 | PubMed |
| 18 | 16330937 | Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. | Am J Surg Pathol | 2006 | https://conductscience.org/library/papers/16330937 | PubMed |
| 19 | 28009604 | Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis? | Am J Surg Pathol | 2017 | https://conductscience.org/library/papers/28009604 | PubMed |
| 20 | 26457355 | Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis. | Am J Surg Pathol | 2015 | https://conductscience.org/library/papers/26457355 | PubMed |
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930552 | From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42930552 | PubMed |
| 42826833 | Targeting p300/CBP destabilizes HIF-2α and suppresses tumor growth in cell and animal models of clear cell renal cell carcinoma. | Cancer Lett | 2026 | https://conductscience.org/library/papers/42826833 | PubMed |
| 41899560 | TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899560 | PubMed |
| 41869663 | Rare renal tumor: a case report of collecting duct carcinoma and literature review. | Front Oncol | 2026 | https://conductscience.org/library/papers/41869663 | PubMed |
| 41634405 | Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41634405 | PubMed |
| 41445911 | Clinicopathological Characteristics and Survival Outcome among Patients with Renal Cell Carcinoma: A Northern Malaysian Experience. | South Asian J Cancer | 2025 | https://conductscience.org/library/papers/41445911 | PubMed |
| 41426798 | Sarcomatoid and Unclassified Renal Neoplasms: Histology, Immunology, and Genomics. | Cureus | 2025 | https://conductscience.org/library/papers/41426798 | PubMed |
| 41400361 | Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. | Histopathology | 2026 | https://conductscience.org/library/papers/41400361 | PubMed |
| 41384711 | Recent developments in eosinophilic renal neoplasms: what's new, true and important? | Histopathology | 2026 | https://conductscience.org/library/papers/41384711 | PubMed |
| 41280159 | Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know? | Eur Urol Open Sci | 2025 | https://conductscience.org/library/papers/41280159 | PubMed |
| 41219889 | Clear cell renal cell carcinoma with collecting duct carcinoma transformation: a case report and review of the literature. | BMC Urol | 2025 | https://conductscience.org/library/papers/41219889 | PubMed |
| 39438706 | The clinical outcome, pathologic spectrum, and genomic landscape for 454 cases of salivary mucoepidermoid carcinoma. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39438706 | PubMed |
| 39335124 | Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39335124 | PubMed |
| 39078524 | Imaging of Chromophobe Renal Cell Carcinoma with 99mTc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification. | Mol Imaging Biol | 2024 | https://conductscience.org/library/papers/39078524 | PubMed |
| 38907039 | Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosis. | Nat Rev Urol | 2025 | https://conductscience.org/library/papers/38907039 | PubMed |
| 38791935 | Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38791935 | PubMed |
| 37849802 | The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/37849802 | PubMed |
| 37762660 | Exosomes in the Diagnosis and Treatment of Renal Cell Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762660 | PubMed |
| 37537362 | A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia. | Sci Rep | 2023 | https://conductscience.org/library/papers/37537362 | PubMed |
| 37438709 | Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37438709 | PubMed |
Genes72
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32251007
GET https://conductscience.org/api/papers/v1/32251007/references?page=2